IL134151A0 - Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity - Google Patents
Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavityInfo
- Publication number
- IL134151A0 IL134151A0 IL13415198A IL13415198A IL134151A0 IL 134151 A0 IL134151 A0 IL 134151A0 IL 13415198 A IL13415198 A IL 13415198A IL 13415198 A IL13415198 A IL 13415198A IL 134151 A0 IL134151 A0 IL 134151A0
- Authority
- IL
- Israel
- Prior art keywords
- controlled release
- oral cavity
- polymer compositions
- pharmaceutical agents
- tannic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89912197A | 1997-07-23 | 1997-07-23 | |
| PCT/US1998/015096 WO1999004764A1 (en) | 1997-07-23 | 1998-07-22 | Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL134151A0 true IL134151A0 (en) | 2001-04-30 |
Family
ID=25410514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13415198A IL134151A0 (en) | 1997-07-23 | 1998-07-22 | Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1003483A1 (en) |
| JP (1) | JP2001510788A (en) |
| KR (1) | KR20010021911A (en) |
| AU (1) | AU8578498A (en) |
| BR (1) | BR9811478A (en) |
| CA (1) | CA2296654A1 (en) |
| HU (1) | HUP0002490A2 (en) |
| IL (1) | IL134151A0 (en) |
| NO (1) | NO20000284L (en) |
| WO (1) | WO1999004764A1 (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7674480B2 (en) | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| EP1305021A4 (en) * | 2000-06-23 | 2009-09-23 | Teva Pharma | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| US6881420B2 (en) | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
| ES2288823T3 (en) * | 2000-09-01 | 2008-02-01 | Cognis Ip Management Gmbh | AGENT FOR ORAL AND DENTAL CARE. |
| JP4820024B2 (en) | 2001-01-10 | 2011-11-24 | 昭和薬品化工株式会社 | Local anesthetic composition |
| JP5089840B2 (en) * | 2001-09-25 | 2012-12-05 | 救急薬品工業株式会社 | Nicotine-containing film preparation |
| EP1446167A4 (en) * | 2001-11-05 | 2010-09-29 | Orahealth Corp | Treating canker sores with patches to speed healing and relieve pain |
| CA2518329C (en) | 2003-03-12 | 2015-11-24 | Epitome Pharmaceuticals Limited | Rapidly absorbing lipophilic skin compositions and uses therefor |
| US20040185009A1 (en) * | 2003-03-19 | 2004-09-23 | Dexcel Pharma Technologies Ltd. | Composition and device for treating periodontal diseases |
| JP4931596B2 (en) | 2003-11-07 | 2012-05-16 | ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー | Tobacco composition |
| US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
| WO2005048965A2 (en) * | 2003-11-13 | 2005-06-02 | Wm. Wrigley Jr. Company | Method and composition for breath freshening |
| ES2400687T3 (en) * | 2004-04-23 | 2013-04-11 | Amgen Inc. | Sustained Release Formulations |
| CA2649149A1 (en) * | 2006-04-11 | 2007-10-25 | Koko Kosmetikvertrieb Gmbh & Co. Kg | Nanoparticle containing nicotine and/or cotinine, dispersions, and use thereof |
| US8642088B2 (en) | 2009-09-04 | 2014-02-04 | Wisconsin Alumni Research Foundation | Tannin-chitosan composites |
| KR101307367B1 (en) | 2010-09-14 | 2013-09-25 | 주식회사 이노테라피 | Adhesive composition comprising tannin, polyethylene glycol, and water, low carbon alcohol or the mixture thereof |
| US8865198B2 (en) | 2010-10-25 | 2014-10-21 | Dexcel Pharma Technologies Ltd. | Method for treating a periodontal disease |
| FR2972327B1 (en) * | 2011-03-11 | 2017-08-11 | Laboratoires Le Stum | MUCOADHESIVE NUTRACEUTICAL COMPOSITION COMPRISING ANTIOXIDANT ASSOCIATION |
| GB2496654A (en) * | 2011-11-18 | 2013-05-22 | Reckitt & Colman Overseas | Self-assembling peptides |
| US20130158132A1 (en) * | 2011-12-19 | 2013-06-20 | Aida Salatinjants | Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans |
| WO2015167257A1 (en) * | 2014-04-29 | 2015-11-05 | 포항공과대학교 산학협력단 | Composition for oral application and method for preparing same |
| RU2606589C2 (en) * | 2015-02-16 | 2017-01-10 | Александр Александрович Кролевец | Method of producing tannin nanocapsules |
| US10532046B2 (en) * | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
| CA3146610A1 (en) * | 2019-08-16 | 2021-02-25 | Adel Penhasi | Adhesive drug delivery microparticles and a product comprising thereof |
| CN115477920A (en) * | 2021-06-15 | 2022-12-16 | 西南大学 | Preparation method of tannin-based underwater adhesive and product |
| KR20230146888A (en) | 2022-04-13 | 2023-10-20 | 경북대학교 산학협력단 | Drug sustained-release self-healing coating layer for dental restoration and manufacturing method thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB104609A (en) * | 1916-06-05 | 1917-03-15 | Monneron & Guye | A Method of Manufacturing a Medicinal Aluminium Preparation. |
| GB918754A (en) * | 1959-08-14 | 1963-02-20 | Armour & Co | Improvements in or relating to corticotrophin preparations |
| GB2036750B (en) * | 1978-11-23 | 1983-05-05 | Payne M | Tannin complexes |
| JPS5846011A (en) * | 1981-09-14 | 1983-03-17 | Kao Corp | Hair treatment |
| JPH01166763A (en) * | 1987-12-22 | 1989-06-30 | Nitta Gelatin Inc | Medical and dental curable material |
| AU2252388A (en) * | 1988-05-02 | 1989-11-29 | Zila Pharmaceuticals | Compositions and in situ methods for forming films on body tissue |
| JPH04114655A (en) * | 1990-09-03 | 1992-04-15 | Shinonaga Kasei Kk | Hard composition for medical use |
| JPH04312522A (en) * | 1991-04-08 | 1992-11-04 | Yoshiaki Kawashima | Production of sustained release tablet |
| JP3496727B2 (en) * | 1993-12-27 | 2004-02-16 | 救急薬品工業株式会社 | Pharmaceutical base |
| JPH08319232A (en) * | 1995-03-22 | 1996-12-03 | Takeda Chem Ind Ltd | Particulate composition |
| JP2885668B2 (en) * | 1995-09-29 | 1999-04-26 | 沢井製薬株式会社 | Teprenone formulation |
-
1998
- 1998-07-22 CA CA002296654A patent/CA2296654A1/en not_active Abandoned
- 1998-07-22 BR BR9811478-6A patent/BR9811478A/en not_active Application Discontinuation
- 1998-07-22 KR KR1020007000475A patent/KR20010021911A/en not_active Application Discontinuation
- 1998-07-22 EP EP98936955A patent/EP1003483A1/en not_active Withdrawn
- 1998-07-22 AU AU85784/98A patent/AU8578498A/en not_active Abandoned
- 1998-07-22 WO PCT/US1998/015096 patent/WO1999004764A1/en not_active Application Discontinuation
- 1998-07-22 HU HU0002490A patent/HUP0002490A2/en unknown
- 1998-07-22 IL IL13415198A patent/IL134151A0/en unknown
- 1998-07-22 JP JP2000503824A patent/JP2001510788A/en not_active Withdrawn
-
2000
- 2000-01-20 NO NO20000284A patent/NO20000284L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0002490A2 (en) | 2000-12-28 |
| AU8578498A (en) | 1999-02-16 |
| WO1999004764A1 (en) | 1999-02-04 |
| NO20000284D0 (en) | 2000-01-20 |
| KR20010021911A (en) | 2001-03-15 |
| EP1003483A1 (en) | 2000-05-31 |
| BR9811478A (en) | 2000-08-15 |
| JP2001510788A (en) | 2001-08-07 |
| CA2296654A1 (en) | 1999-02-04 |
| NO20000284L (en) | 2000-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL134151A0 (en) | Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity | |
| IL123986A0 (en) | Antithombotic agents process for their preparation and pharmaceutical compositions comprising them | |
| HUP0201376A2 (en) | Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds | |
| HUP9800985A3 (en) | Retarde polymere compositions for pharmaceutical compositions | |
| EG23875A (en) | Oral pharmaceutical pulsed release dosage form | |
| HUP0203542A3 (en) | 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same | |
| IL138280A0 (en) | 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
| EP1043031A4 (en) | Sustained release medicinal compositions | |
| HUP0204519A3 (en) | 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations | |
| IL136938A0 (en) | 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
| ZA986889B (en) | Controlled release pharmaceutical compositions containing tiagabine | |
| HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
| HUP0202762A3 (en) | Solid lipid compositions, process for their preparation and use thereof | |
| HUP0102215A3 (en) | Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation | |
| HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
| HUP9803040A3 (en) | Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them | |
| EG24463A (en) | Modified release pharmaceutical composition | |
| HUP0105308A3 (en) | Eletriptan hydrobromide monohydrate, process for its preparation and pharmaceutical compositions containing the same | |
| HUP0104544A2 (en) | New pharmaceutical composition and the process for its preparation | |
| HUP0003159A3 (en) | The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions | |
| ZA99168B (en) | Pharmaceutical formulations and processes for their preparation. | |
| HUP9803041A3 (en) | Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them | |
| HUP0004132A3 (en) | Rapidly soluble drug composition | |
| ZA983205B (en) | Sustained release compositions and the process for their preparation | |
| HUP0001234A3 (en) | Pharmaceutical composition for the programmed release of dexfenfluramine |